- 11:24 PM Student visa applications to US, UK see 25% drop
- 10:46 PM Astec LifeSciences to start a project in Q3FY11
- 10:20 PM Rangebound session for Nifty ahead of Nov series e...
- 09:30 PM Politics stirs over Ayodhya mosque report
- 09:23 PM Clean energy, better homes cut pollution, save liv...
- 09:11 PM US to face stimulus aftershocks: Warren Buffett
- 09:02 PM Expert stock/sector picks for tricky markets
- 08:53 PM Indian techie logging out of downturn gloom
- 08:52 PM Expert stock/sector picks in these markets
- 08:44 PM Govt not to relook at arrested CLB member's probe
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted approval for the company’s Abbreviated New Drug Application (ANDA) for generic Sinemet CR, an extended release version of carbidopa with levodopa.
Carbidopa with levodopa extended release is indicated for the treatment of Parkinson’s disease and syndrome.
These generic extended release versions of carbidopa with levodopa are bio-equivalent to Sinemet CR® marketed by Bristol-Myers and Squibb Company and will be available as tablets in two strengths: 25 mg carbidopa with 100 mg levodopa and 50 mg carbidopa with 200 mg levodopa.
These strengths of carbidopa with levodopa generic and branded products had annual sales of approximately USD 66 million in the US.
The Company expects to reach the market shortly with these products.
Sourced From: Sun Pharmaceutical Industries Ltd
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- US to face stimulus aftershocks: Warren Buffett
- Expert stock/sector picks in these markets
- India to sell $70 bn shares in 3 years: Morgan Stanley
- Mkts to remain strong; bet on midcaps: Ramesh Damani
- Nifty to test 5500 post 5-7% correction: JM Financial
- Satyam says no out-of-court settlement with creditors
- Student visa applications to US, UK see 25% drop
- Sell Mahindra Satyam: Sandeep Wagle
- S&P raises fears over health of some banks
Source: ft.com
- Auto sector growth to push up demand for rubber
Source: Business Line
- High networth individuals see glitter in commodities
Source: Business Line
- Tatas may launch electric Indica by early 2011
Source: Business Line
